|
1
|
Center MM, Jemal A, Smith RA and Ward E:
Worldwide variations in colorectal cancer. CA Cancer J Clin.
59:366–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Beelman CA and Parker R: Degradation of
mRNA in eukaryotes. Cell. 81:179–183. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ross J: Control of messenger RNA stability
in higher eukaryotes. Trends Genet. 12:171–175. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arribas-Layton M, Wu D, Lykke-Andersen J
and Song H: Structural and functional control of the eukaryotic
mRNA decapping machinery. Biochim Biophys Acta. 1829:580–589. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eulalio A, Behm-Ansmant I, Schweizer D and
Izaurralde E: P-body formation is a consequence, not the cause, of
RNA-mediated gene silencing. Mol Cell Biol. 27:3970–3981. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Franks TM and Lykke-Andersen J: The
control of mRNA decapping and P-body formation. Mol Cell.
32:605–615. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Anderson P, Kedersha N and Ivanov P:
Stress granules, P-bodies and cancer. Biochim Biophys Acta.
1849:861–870. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cougot N, Daguenet E, Baguet A, Cavalier
A, Thomas D, Bellaud P, Fautrel A, Godey F, Bertrand E, Tomasetto C
and Gillet R: Overexpression of MLN51 triggers P-body disassembly
and formation of a new type of RNA granules. J Cell Sci.
127:4692–4701. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Anderson P and Kedersha N: RNA granules:
Post-transcriptional and epigenetic modulators of gene expression.
Nat Rev Mol Cell Biol. 10:430–436. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aizer A, Kafri P, Kalo A and Shav-Tal Y:
The P body protein Dcp1a is hyper-phosphorylated during mitosis.
PLoS One. 8:e497832013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen VW, Hsieh MC, Charlton ME, Ruiz BA,
Karlitz J, Altekruse SF, Ries LA and Jessup JM: Analysis of stage
and clinical/prognostic factors for colon and rectal cancer from
SEER registries: AJCC and collaborative stage data collection
system. Cancer. 120 Suppl 23:S3793–S3806. 2014. View Article : Google Scholar
|
|
16
|
Barclay KL, Goh PJ and Jackson TJ:
Socio-economic disadvantage and demographics as factors in stage of
colorectal cancer presentation and survival. ANZ J Surg.
85:135–139. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feroci F and Fong Y: Use of clinical score
to stage and predict outcome of hepatic resection of metastatic
colorectal cancer. J Surg Oncol. 102:914–921. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yalamati P, Bhongir AV, Karra M and Beedu
SR: Comparative analysis of urinary total proteins by bicinchoninic
acid and pyrogallol red molybdate methods. J Clin Diagn Res.
9:BC01–BC04. 2015.PubMed/NCBI
|
|
20
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Edwards BK, Ward E, Kohler BA, Eheman C,
Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I,
Seeff LC, et al: Annual report to the nation on the status of
cancer, 1975–2006, featuring colorectal cancer trends and impact of
interventions (risk factors, screening, and treatment) to reduce
future rates. Cancer. 116:544–573. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shimamoto Y, Nukatsuka M, Takechi T and
Fukushima M: Association between mRNA expression of
chemotherapy-related genes and clinicopathological features in
colorectal cancer: A large-scale population analysis. Int J Mol
Med. 37:319–328. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vallazza B, Petri S, Poleganov MA, Eberle
F, Kuhn AN and Sahin U: Recombinant messenger RNA technology and
its application in cancer immunotherapy, transcript replacement
therapies, pluripotent stem cell induction, and beyond. Wiley
Interdiscip Rev RNA. 6:471–499. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gallie DR: The cap and poly(A) tail
function synergistically to regulate mRNA translational efficiency.
Genes Dev. 5:2108–2116. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Simon E, Camier S and Séraphin B: New
insights into the control of mRNA decapping. Trends Biochem Sci.
31:241–243. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Erickson SL and Lykke-Andersen J:
Cytoplasmic mRNP granules at a glance. J Cell Sci. 124:293–297.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Polunovsky VA and Bitterman PB: The
cap-dependent translation apparatus integrates and amplifies cancer
pathways. RNA Biol. 3:10–17. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wendel HG, De Stanchina E, Fridman JS,
Malina A, Ray S, Kogan S, Cordon-Cardo C, Pelletier J and Lowe SW:
Survival signalling by Akt and eIF4E in oncogenesis and cancer
therapy. Nature. 428:332–337. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fujimura K, Wright T, Strnadel J, Kaushal
S, Metildi C, Lowy AM, Bouvet M, Kelber JA and Klemke RL: A
hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of
pancreatic cancer. Cancer Res. 74:6671–6681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang W, Liu H, Yin J, Wu W, Zhu D, Amos
CI, Fang S, Lee JE, Li Y, Han J and Wei Q: Genetic variants in the
PIWI-piRNA pathway gene DCP1A predict melanoma disease-specific
survival. Int J Cancer. 139:2730–2737. 2016. View Article : Google Scholar : PubMed/NCBI
|
